Share
eBlogs
In this end-of-year eBlog, our team reflects on the successes of RNA research and drug development in 2024.
Our CEO, Peter Chu, reflects on the successes of the past year and looks forward to 2025 in this Thanksgiving-themed eBlog.
In this eBlog we discuss the mechanisms of siRNA off-target interactions and outlines strategies to minimize them.
RNA secondary structure is a key determinant of RNA biology and therapeutic efficacy. In this eBlog, we review how RNA structure affects the development of RNA vaccines, siRNAs, and ASOs.